Glycated Hemoglobin Variability Is Associated With Adverse Outcomes in Patients With Heart Failure Irrespective of Diabetic Status.
Xin XuQing-Wen RenChanchal ChandramouliMing-Yen NgChristopher Tze-Wei TsangYi-Kei TseXin-Li LiMing-Ya LiuMei Zhen WuJia-Yi HuangIok-Fai CheangJie-Fu YangFang WangCarolyn Su Ping LamKai-Hang YiuPublished in: Journal of the American Heart Association (2024)
variability is significantly associated with greater risk of rehospitalization and all-cause death in patients with HF, irrespective of their diabetic status. These observations were more pronounced in patients with HF without diabetes.